The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s implantable cardiac rhythm management device market report forecasts the implantable cardiac rhythm management device market size to grow to $20.52 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Implantable Cardiac Rhythm Management Device Market Report 2023 – https://www.thebusinessresearchcompany.com/report/implantable-cardiac-rhythm-management-device-global-market-report

Implantable Cardiac Rhythm Management Device Market Size Forecast
The global implantable cardiac rhythm management device market is expected to grow from $15.37 billion in 2022 to $16.43 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The global implantable cardiac rhythm management device market size is expected to reach $20.52 billion in 2027 at a CAGR of 5.7%.

North America held the largest implantable cardiac rhythm management device market share.

Key Implantable Cardiac Rhythm Management Device Market Driver ­– Increase In The Prevalence Of Cardiac Disorders
According to a report published by the American Heart Association, a non-profit organisation located in the United States dedicated to treating heart disease and stroke, cardiovascular disease (CVD) was responsible for approximately 19.1 million deaths worldwide in 2020. The age-adjusted death rate was 239.8 individuals per 100,000. As a result, the rising prevalence of cardiac problems is propelling the implantable cardiac rhythm management devices market forward.

Request for A Sample Of The Global Implantable Cardiac Rhythm Management Device Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10117&type=smp

Key Implantable Cardiac Rhythm Management Device Market Trend – Technological Advancement
To maintain their market position, major businesses in the implantable cardiac rhythm management devices market are focusing on creating innovative technologies. For example, Rhythm Management Group PLLC, a US-based firm that provides continual cardiac device monitoring for implantable cardiac devices, unveiled RhythmSynergy, a powerful new technological platform, in April 2022. It use machine learning to give timely and relevant clinical insights to patients being remotely monitored who have implantable cardiac devices and wearable devices such as blood pressure cuffs, scales, and glucometers. By combining clinical knowledge and machine learning technologies, RhythmSynergy highlights critical information and speeds review processes. Its clean, secure architecture and powerful reporting capabilities make reviewing, sharing, and analysing patient data straightforward.

Implantable Cardiac Rhythm Management Device Market Segment
1) By Device: Cardiac Resynchronization Therapy, Defibrillators, Pacemakers
2) By Application: Bradycardia, Tachycardia, Other Applications
3) By End-Use: Hospitals, Specialty Cardiac Centers, Other End-Uses

Implantable Cardiac Rhythm Management Device Market Major Players and Strategies
Major players in the implantable cardiac rhythm management device market are Stryker Corporation, Schiller AG, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Zoll Medical Corporation, Biotronik, MicroPort Scientific Corporation, Abiomed Inc, Hydrix Limited, Nihon Kohden Corporation, Japan Lifeline Co. Ltd., Lepu Medical Technology (Beijing) Co. Ltd., and LivaNova PLC.

Medtronic, a medical technology business based in the United States, paid an unknown sum for Affera Inc. in August 2022. Medtronic gains access to the Affera Prism-1TM cardiac mapping and navigation platform, which is expected to be interoperable with both Medtronic therapeutic catheters and a number of rival technologies as a result of this transaction. Affera Inc. is a medical technology firm established in the United States that develops cardiac mapping and navigation devices for the treatment of patients suffering from cardiac arrhythmias.

The Implantable Cardiac Rhythm Management Device Global Market Report 2023 covers regional data on implantable cardiac rhythm management device market size, implantable cardiac rhythm management device market trends and drivers, opportunities, strategies, and implantable cardiac rhythm management device market competitor analysis. The countries covered in the implantable cardiac rhythm management device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Implantable cardiac rhythm management devices are small battery-powered devices that are implanted inside the body and linked to the heart. It is used to keep and manage the cardiac rhythm.

View More Reports Related To The Implantable Cardiac Rhythm Management Device Market –
Cardiac Assist Devices And Equipment Global Market Report 2023
Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2023
Implantable Biomaterials Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: